Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction
Open Access
- 1 August 2002
- Vol. 88 (2) , 125-130
- https://doi.org/10.1136/heart.88.2.125
Abstract
Objective: To assess the prevalence of myocardial viability by technetium-99m (Tc-99m)-tetrofosmin/fluorine-18-fluorodeoxyglucose (FDG) single photon emission computed tomography (SPECT) in patients with ischaemic cardiomyopathy. Design: A retrospective observational study. Setting: Thoraxcenter Rotterdam (a tertiary referral centre). Patients: 104 patients with chronic coronary artery disease and severely depressed left ventricular function presenting with heart failure symptoms. Main outcome measures: Prevalence of myocardial viability as evaluated by Tc-99m-tetrofosmin/FDG SPECT imaging. Two strategies for assessing viability in dysfunctional myocardium were used: perfusion imaging alone, and the combination of perfusion and metabolic imaging. Results: On perfusion imaging alone, 56 patients (54%) had a significant amount of viable myocardium, whereas 48 patients (46%) did not. Among the 48 patients with no significant viability by perfusion imaging alone, seven additional patients (15%) had significantly viable myocardium on combined perfusion and metabolic imaging. Thus with a combination of perfusion and metabolic imaging, 63 patients (61%) had viable myocardium and 41 (39%) did not. Conclusions: On the basis of the presence of viable dysfunctional myocardium, 61% of patients with chronic coronary artery disease and depressed left ventricular ejection fraction presenting with heart failure symptoms may be considered for coronary revascularisation. The combination of perfusion and metabolic imaging identified more patients with significant viability than myocardial perfusion imaging alone.Keywords
This publication has 31 references indexed in Scilit:
- The hibernating myocardiumPublished by Elsevier ,2004
- Prediction of global left ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolismEuropean Heart Journal, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunctionThe American Journal of Cardiology, 1998
- Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunctionJAMA, 1994
- Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunctionThe American Journal of Cardiology, 1994
- Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defectsJournal of the American College of Cardiology, 1994
- Coronary artery bypass grafting in severe left ventricular dysfunction: Excellent survival with improved ejection fraction and functional stateJournal of the American College of Cardiology, 1993
- Natural history and patterns of current practice in heart failureJournal of the American College of Cardiology, 1993